Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Imipenem
by Most Market Reports in the France in 2019

The Imipenem top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Market Reports Imipenem Key Players in the France. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Imipenem (Primaxin among others) is an intravenous β-lactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in the mid-1970s. Carbapenems are highly resistant to the β-lactamase enzymes produced by many multiple drug-resistant Gram-negative bacteria, thus play a key role in the treatment of infections not readily treated with other antibiotics.
#
Company Name
Region
Tech Topics
Total
1
Deinove SA
Antibiotics,Chemical engineering,Biotechnology,
...[+2]
market report: 1
2
Pherecydes Pharma SA
Phage therapy,Medical equipment,Health care,
...[+2]
market report: 1
3
Sanofi-Aventis Participations SAS
Insulin,Medicine,Biology
market report: 1
4
Eligo Bioscience SA
Antimicrobial,Health care,CRISPR,
...[+2]
market report: 1
5
Antabio SAS
Carbapenem,Biology,Medicine,
...[+2]
market report: 1
6
Mutabilis SA
Virulence,Medicine,Anti-Infective Agents,
...[+2]
market report: 1
7
Nosopharm SAS
Drug discovery,Medicine,Antibiotics,
...[+2]
market report: 1
8
Vibiosphen
Antibiotic resistance,Biotechnology,Antibiotics,
...[+2]
market report: 1
9
Eydo Pharma SAS
Medicine,Aminoglycoside,Penicillin,
...[+2]
market report: 1
10
Da Volterra
Antibiotic resistance,Biopharmaceutical,Clostridium,
...[+2]
market report: 1
Page generation time: Apr 28 2025